Gifu, Japan

Yoshihito Ueno

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Japan Science and Technology Agency, National University Corporation Tokai National Higher Education and Research System, Yamasa Corporation. Active years: 2009-2025.

USPTO Granted Patents = 7 

% Patents Active = 71.4

 

 

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2009-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Yoshihito Ueno

Introduction

Yoshihito Ueno is a prominent inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleoside derivatives. With a total of 7 patents to his name, Ueno's work has the potential to impact various applications in medicine.

Latest Patents

Ueno's latest patents include innovative nucleoside derivatives that are represented by specific chemical formulas. One of his notable inventions is a nucleoside derivative that is more practical for RNA pharmaceuticals. This invention is characterized by its unique structural formulas, which allow for various substitutions that enhance its efficacy in medical applications.

Career Highlights

Throughout his career, Ueno has worked with esteemed organizations such as the Japan Science and Technology Agency and the Tokai National Higher Education and Research System. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ueno has collaborated with notable colleagues, including Yukio Kitade and Yusuke Maeda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshihito Ueno's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in RNA pharmaceuticals and other applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…